US Stock MarketDetailed Quotes
ALZN Alzamend Neuro
- 0.7260
- -0.0090-1.22%
Close May 3 16:00 ET
- 0.7260
- 0.00000.00%
Post 16:19 ET
4.99MMarket Cap-398P/E (TTM)
0.7400High0.7152Low18.97KVolume0.7350Open0.7350Pre Close13.83KTurnover0.39%Turnover RatioLossP/E (Static)6.87MShares11.910052wk High-1.17P/B3.51MFloat Cap0.651652wk Low--Dividend TTM4.83MShs Float503.2500Historical High--Div YieldTTM3.37%Amplitude0.6516Historical Low0.7280Avg Price1Lot Size
Alzamend Neuro News
Buy Rating Justified by Alzamend Neuro's Promising Alzheimer's Treatments and Attractive Valuation
Buy Rating for Alzamend Neuro Amid Promising Alzheimer's Drug Trials and Market Potential
Promising Developments in Alzamend Neuro's Clinical Trials Bolster Buy Rating: A Focused Review on AL001's Potential in Mental Health Treatment
Maxim Group Reaffirms Their Buy Rating on Alzamend Neuro (ALZN)
Ascendiant Sticks to Their Buy Rating for Alzamend Neuro (ALZN)
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg